Similar articles

• Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.

  Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Ho DD, et al. Nature. 1995 Jan 12;373(6510):123-6. doi: 10.1038/373123a0. Nature. 1995. PMID: 7816094
• The current role of ritonavir-boosted protease inhibitors in the management of HIV infection.

  Wilkins E. Wilkins E. J HIV Ther. 2008 Mar;13(1):9-18. J HIV Ther. 2008. PMID: 18953268 Review. No abstract available.
• HIV-1 dynamics in vivo: implications for therapy.

  Simon V, Ho DD. Simon V, et al. Nat Rev Microbiol. 2003 Dec;1(3):181-90. doi: 10.1038/nrmicro772. Nat Rev Microbiol. 2003. PMID: 15035022 Review.
• [Viral dynamics in the course of HIV-1 infection: pathogenetic features and new therapeutic prospects].

  Marcello A, Giacca M. Marcello A, et al. Pathologica. 2000 Aug;92(4):291-3. Pathologica. 2000. PMID: 11029891 Italian. No abstract available.
• Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy.

  Chun TW, Engel D, Mizell SB, Hallahan CW, Fischette M, Park S, Davey RT Jr, Dybul M, Kovacs JA, Metcalf JA, Mican JM, Berrey MM, Corey L, Lane HC, Fauci AS. Chun TW, et al. Nat Med. 1999 Jun;5(6):651-5. doi: 10.1038/9498. Nat Med. 1999. PMID: 10371503 Clinical Trial.